Compliance & EnforcementResources
ArchiveResources
1,265 articles from the Compliance & Enforcement Brief.
Articles
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.
Cost of Medication Not Evidence of False Claims
Amentum Back in as Defendant in Human Trafficking, Contract Fraud Complaint
Three Amended Complaints Not Too Many
Anti-Kickback Compliance Predates Affordable Care Act Amendments to the FCA
News Articles Disclosed Hospital Owner’s Role Providing Bank Loans to Physicians
Copays Are Not Equivalent to Insurance Benefits Under ACA
Decision to Terminate – Not Notice to Employee – Starts the Clock on Retaliation Complaint
No Safe Harbor for Payments Intended to Induce Referrals, Regardless of Fair Market Value
State Has Same Right as DOJ to Dismiss Qui Tam Action
Nuclear Lab Employees Won’t Have to Testify About Sensitive Information
Defendants Win Rare Reconsideration on Question of Materiality
First-to-File Bar Prevents Relators from Recovering Attorney Fees, Even When They Shared the Government’s Recovery
Appeal Saves FCA Defendant On Damages
Settlement Agreement Requires Relator to Ask Government to Drop Qui Tam Complaint, but Government Does Not Have to Consent
Fifth Circuit Declines to Reinstate Walgreens FCA Suit
Without Evidence, Allegations of Domestic Abuse Insufficient to Maintain Seal on Qui Tam Action
False Claims Act: 2021 Year in Review
Neither Swift Nor Sequoia – First Circuit Charts Own Path on DOJ Veto Authority; U.S. and California ex rel. John R. Borzilleri M.D. v Bayer Healthcare Pharmaceuticals Inc., United States Court of Appeals for the First Circuit No. 20-1066
Seventh Circuit Reverses District Court On Dismissal Over Particularity; United States Court of Appeals for the Seventh Circuit No. 19-3117, U.S. e rel. John Mamalakis v. Anesthetix Management LLC, et al.
Keep reading
